On December 2, 2019 Innovative Medicines Canada (IMC) published
a revised version of its Code of Ethical Practices (IMC Code)(PDF).
These changes are intended to ensure that relationships between
the innovative pharmaceutical industry and various stakeholders,
including notably, healthcare professionals (HCPs), follow the
highest ethical standards. Among other things, we note additional,
more stringent restrictions regarding compensation of prescribing
HCPs.
There are five major updates to the Code:
1. Guiding Principles
To begin, it is now explicit that the guiding principles apply
throughout the IMC Code and should be read into all sections. The
guiding principles are intended to provide interpretations of the
IMC Code and assist members in respecting the spirit of the IMC
Code where no specific provisions apply.